Sign in

Research summary ·

Oral, intravenous, or sequential alpha-lipoic acid for diabetic peripheral neuropathy? A Bayesian network meta-analysis of randomized controlled trials.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at alpha-lipoic acid, or ALA, for nerve damage from diabetes. ALA can be given by mouth, into a vein, or both in turn. The team pooled results from randomized trials found in large databases. Doses in the trials ran from 600 to 1,800 mg a day. Treatment lasted from 3 to 208 weeks. They used a method that can compare and rank many options at once.

What they found

At first, giving ALA both ways in turn looked strongest. But the trials of that plan had a high risk of bias. When biased trials were left out, this lead went away. ALA into a vein then ranked top for quick relief of symptoms. It also ranked top for overall signs of nerve damage. The authors say this route avoids stomach and gut risks. ALA by mouth ranked top for nerve damage in the lower limbs. Both the vein and the mouth routes made people more pleased overall.

What it means for patients

The authors say the way ALA works well may depend on the stage. In their view, ALA into a vein gives fast early help. They see ALA by mouth as key for long-term repair in the lower limbs. They say this backs the idea of a start phase, then a keep-up phase.

Why it is not certain yet

There is little unbiased proof for the plan that uses both ways in turn. The trials that tested that plan had serious bias. The authors call for large, double-blind trials. Doses and lengths of treatment were not the same across trials. A review can only be as good as the studies in it.

Source

Oral, intravenous, or sequential alpha-lipoic acid for diabetic peripheral neuropathy? A Bayesian network meta-analysis of randomized controlled trials.

PubMed · PMID 42643396

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic neuropathy publications